Mesenchymal Stem Cells Enhance the Impact of KIR Receptor-Ligand Mismatching on Acute Graft-versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia but Not in Those with Acute Lymphocytic Leukemia

0
18
To investigate the potential influence of killer cell immunoglobulin‐like receptor (KIR) matching and mesenchymal stem cells, and their synergism on acute and chronic graft‐versus‐host disease after allo‐hematopoietic stem cell transplantation in acute myeloid leukemia and acute lymphoblastic leukemia patients.
[Hematological Oncology]
Zhang, Y., Zheng, H., Ren, J., Luo, X., Zheng, Z., Zheng, J., Zheng, X., Chen, Y., Chen, Z., Hu, J., & Yang, T. (n.d.). Mesenchymal stem cells enhance the impact of KIR receptor-ligand mismatching on acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia but not in those with acute lymphocytic leukemia. Hematological Oncology, n/a(n/a). https://doi.org/https://doi.org/10.1002/hon.2867 Cite
Abstract